Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


GreenScreen HC

Product Image
Product Description

GreenScreen® HC is an accurate and fast in vitro human cell-based assay for the assessment of genotoxicity and cytotoxicity of compounds and mixtures.

The assay detects substances that are capable of causing damage to genetic material (DNA) within a cell. GreenScreen HC uses the human-derived, p53 competent, TK6 cell line to host a patented green fluorescent protein (GFP) reporter  system which exploits the proper regulation of the GADD45a gene.

Exposure to a genotoxic compound increases the expression of GADD45a and hence the induction of GFP production in the test strain. Simultaneous quantification of relative cell density or cell viability allows assessment of cytotoxicity.

•    Unique combination of high specificity and high sensitivity for genotoxicity
•    Detects all mechanistic classes of genotoxin (mutagens, aneugens and clastogens)
•    Most accurate genotoxicity screening test available
•    Simple, robust and fast protocol
•    Low sample requirement

The 96-well microplate format takes about 20 minutes to prepare and delivers results after a 48 hour incubation. A single microplate is used for the simultaneous testing of 4 compounds over 9 serial dilutions. The protocol is readily automated using standard laboratory equipment.

Product GreenScreen HC
Company Gentronix Ltd.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Gentronix Ltd.
BioHub at Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom

Tel: +44 (0)1625 238700
Fax: +44 (0)1625 238701
Email: info@gentronix.co.uk



Scientific News
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!